HIV

Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir

Authors: Kevin Robertson, Paul Maruff, Lisa L. Ross, David Wohl, Catherine B Small, Howard Edelstein & Mark S. Shaefer

Journal: Journal of Neurovirology

Year Published: 2019

Human immunodeficiency virus (HIV)-associated neurocognitive disorders can persist in many patients despite achieving viral suppression while on antiretroviral therapy (ART). Neurocognitive function over 48 weeks was evaluated using a Cogstate test battery assessing psychomotor function, attention, […]

Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition

Authors: ER Elliot, X Wang, S Singh, B Simmons, JH Vera, RF Miller, C Fitzpatrick, G Moyle, M McClure, M Boffito

Journal: Clinical Infectious Diseases

Year Published: 2019

Background: Demographic data show an increasingly aging human immunodeficiency virus (HIV) population worldwide. Recent concerns over dolutegravir-related neuropsychiatric toxicity have emerged, particularly amongst older people living with HIV (PLWH). We describe the pharmacokinetics (PK) of dolutegravir […]

Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment

Authors: Gustaf Ulfhammer, Arvid Edén, Åsa Mellgren, Dietmar Fuchs, Henrik Zetterberg, Lars Hagberg, Staffan Nilsson, Aylin Yilmaz, Magnus Gisslén

Journal: Aids

Year Published: 2018

Objective Low-grade immune activation is common in people living with HIV (PLHIV), despite long-term viral suppression by antiretroviral therapy (ART). The clinical significance of this activation remains unclear. The aim of this study was to examine […]

CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study

Authors: T J Barber, A Imaz, M Boffito, J Niubó, A Pozniak, R Fortuny, J Alonso, N Davies, S Mandalia, D Podzamczer, B Gazzard

Journal: Journal of Neurovirology

Year Published: 2018

CINAMMON is a phase IV, open-label, single-arm, pilot study assessing maraviroc (MVC) in the central nervous system (CNS) when added to darunavir/ritonavir monotherapy (DRV/r) in virologically suppressed HIV-infected subjects. CCR5 tropic participants on DRV/r were recruited. […]

Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals

Authors: Kara R Douglas-Newman, Rachel V Smith, Mary V Spiers, Timothy Pond, Henry R Kranzler

Journal: Addictive Disorders & Their Treatment

Year Published: 2017

Objectives: Although HIV+ individuals may be at increased risk of alcohol-related cognitive impairment, the relations between drinking level and cognitive performance in these individuals are not well understood. We examined whether higher levels of recent drinking […]

1 2 3 4 5 6

Back to Publications